Ascendia® Named to 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies for the Fourth Consecutive Year

— Leading Specialty Pharma CDMO Continues Strong Growth Trend Due to Making the Impossible Possible for Pharmaceutical and Biological Companies – NORTH BRUNSWICK, N.J., Aug. 24, 2023 /PRNewswire/ — Ascendia Pharmaceuticals®, a leading specialty pharmaceutical contract development and…